Research projects
Start of main content
The generation of iPSC cells for the study of neurodevelopmental diseases: autism and William's syndrome
16th national competition for scientific and technical research
Gene and regenerative therapy
Research Centre or Institution : Centros de Investigación Biomédica en Red (CIBER)-Universidad Pompeu Fabra. Barcelona
Abstract
The proposed aims of the first stages of the project chiefly centred on the selection of candidate patients by means of molecular characterisation using genomic arrays, obtaining their informed consent to take part and obtaining biological material (in this case, total blood and a skin biopsy) to commence studies on the generation of iPSC cells. These cells are the key factor in this project, based on the generation of reciprocal genetic models and aimed at discovering the functional bases involved in Williams-Beuren syndrome (WBS) and Autistic Spectrum Disorders (ASD).
In December, 2012, the necessary material is available to start generating iPSC.
- After characterising a large series of candidate patients, samples of 3 patients were selected and recruited with duplication of 7q11.23 (characterised by genomic array) and 2 patients with reciprocal deletion 7q11.13 (by means of MLPA studies and microsatellites). After recruiting patients for the study (with their informed consent), skin biopsies were obtained, from which the fibrocytes were isolated to create the "Induced Pluripotent Stem Cells" cell model. Twenty frozen cryotubes of primary culture are available of each of the cell lines to be studied.
- The presence of the genetic alteration in the fibrocyte cultures was validated using MLPA molecular technique, and a standard kariotype was performed to ensure that there were no additional alterations arising due to the culture process in any of them.
It is planned to commence the process of creating the IPSC in January - February, 2013.
- Activities related
- Projects related
- News related
- Publications related
-
12
Sep
2022
Conferencia online Diseño de materia supramolecular para señalar y emular sistemas vivos ONLINE www.fundacionareces.tv/directo, Monday, 12 September 2022, 19:00 hours
-
26
Sep
2022
Conference Terapia génica y celular avanzada… Más allá de la última frontera Madrid, Monday, 26 September 2022, 19:00 hours
-
9
May
2024
Conference Genes de mosca y genes humanos: una comparación Madrid, Jueves 09 de mayo de 2024, 19:00 horas
- Synthetic nanoparticles as an innovative treatment for sepsis (SPRINT-4-SEPSIS) 2018 Senior Researcher : Antonio Artigas Raventós Research Centre or Institution : Instituto de Investigación e Innovación Parc Taulí (I3PT), Corporación Sanitaria i Universitaria Parc Taulí
- Risk Assesment of Bacterial Sepsis using multiomic and bioinformatics tools: an approach towards the Precision Medicine in Infectious Diseases 2018 Senior Researcher : María Teresa Coque González
- Extracellular vesicles biomarkers for the diagnosis and prognosis of post-surgical septic shock 2018 Senior Researcher : Eduardo Tamayo Gómez Research Centre or Institution : Hospital Clínico Universitario de Valladolid
-
Eric D. Green: “La genómica debe integrarse en la medicina convencional”
Published on 03/12/2021
Stem cells and organoids. Unlocking their potential to understand and treat disease
Febrero 2018 Nature PapersEnd of main content